Inducing synthetic lethality for selective targeting of acute myeloid leukemia cells harboring STAG2 mutations

Agatheeswaran Subramaniam; Carl Sandén; Larissa Moura-Castro; Kristijonas Žemaitis; Ludwig Schmiderer; Aurelie Baudet; Alexandra Bäckström; Elin Arvidsson; Simon Hultmark; Natsumi Miharada; Mattias Magnusson; Kajsa Paulsson; Thoas Fioretos; Jonas Larsson

doi:10.3324/haematol.2021.280303

Inducing synthetic lethality for selective targeting of acute myeloid leukemia cells harboring STAG2 mutations

Agatheeswaran Subramaniam, Carl Sandén, Larissa Moura-Castro, Kristijonas Žemaitis, Ludwig Schmiderer, Aurelie Baudet, Alexandra Bäckström, Elin Arvidsson, Simon Hultmark, Natsumi Miharada, Mattias Magnusson, Kajsa Paulsson, Thoas Fioretos, Jonas Larsson

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	2271-2275
Journal	Haematologica
Volume	107
Issue number	9
Early online date	2022
DOIs	https://doi.org/10.3324/haematol.2021.280303
Publication status	Published - 2022

Subject classification (UKÄ)

Cancer and Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3324/haematol.2021.280303Licence: Unspecified

1 Doctoral Thesis (compilation)

Modeling normal and malignant hematopoiesis in vitro. To screen for extrinsic regulators and differentiation therapy.
Hultmark, S., 2022, Lund: Lund University, Faculty of Medicine. 118 p.
Research output: Thesis › Doctoral Thesis (compilation)

File

Cite this

Subramaniam, A., Sandén, C., Moura-Castro, L., Žemaitis, K., Schmiderer, L., Baudet, A., Bäckström, A., Arvidsson, E., Hultmark, S., Miharada, N., Magnusson, M., Paulsson, K., Fioretos, T., & Larsson, J. (2022). Inducing synthetic lethality for selective targeting of acute myeloid leukemia cells harboring STAG2 mutations. Haematologica, 107(9), 2271-2275. Advance online publication. https://doi.org/10.3324/haematol.2021.280303

@article{81ddb4f8b9d54610906b5c07ff8a7bfb,

title = "Inducing synthetic lethality for selective targeting of acute myeloid leukemia cells harboring STAG2 mutations",

author = "Agatheeswaran Subramaniam and Carl Sand{\'e}n and Larissa Moura-Castro and Kristijonas {\v Z}emaitis and Ludwig Schmiderer and Aurelie Baudet and Alexandra B{\"a}ckstr{\"o}m and Elin Arvidsson and Simon Hultmark and Natsumi Miharada and Mattias Magnusson and Kajsa Paulsson and Thoas Fioretos and Jonas Larsson",

year = "2022",

doi = "10.3324/haematol.2021.280303",

language = "English",

volume = "107",

pages = "2271--2275",

journal = "Haematologica",

issn = "1592-8721",

publisher = "Ferrata Storti Foundation",

number = "9",

}

Subramaniam, A , Sandén, C , Moura-Castro, L , Žemaitis, K , Schmiderer, L , Baudet, A, Bäckström, A, Arvidsson, E, Hultmark, S, Miharada, N , Magnusson, M , Paulsson, K , Fioretos, T & Larsson, J 2022, 'Inducing synthetic lethality for selective targeting of acute myeloid leukemia cells harboring STAG2 mutations', Haematologica, vol. 107, no. 9, pp. 2271-2275. https://doi.org/10.3324/haematol.2021.280303

TY - JOUR

T1 - Inducing synthetic lethality for selective targeting of acute myeloid leukemia cells harboring STAG2 mutations

AU - Subramaniam, Agatheeswaran

AU - Sandén, Carl

AU - Moura-Castro, Larissa

AU - Žemaitis, Kristijonas

AU - Schmiderer, Ludwig

AU - Baudet, Aurelie

AU - Bäckström, Alexandra

AU - Arvidsson, Elin

AU - Hultmark, Simon

AU - Miharada, Natsumi

AU - Magnusson, Mattias

AU - Paulsson, Kajsa

AU - Fioretos, Thoas

AU - Larsson, Jonas

PY - 2022

Y1 - 2022

U2 - 10.3324/haematol.2021.280303

DO - 10.3324/haematol.2021.280303

M3 - Letter

C2 - 35638550

SN - 1592-8721

VL - 107

SP - 2271

EP - 2275

JO - Haematologica

JF - Haematologica

IS - 9

ER -

Inducing synthetic lethality for selective targeting of acute myeloid leukemia cells harboring STAG2 mutations

Subject classification (UKÄ)

UN SDGs

Access to Document

Research output

Modeling normal and malignant hematopoiesis in vitro. To screen for extrinsic regulators and differentiation therapy.

Cite this